Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer | PLOS ONE
![CA15-3 tumor marker level over the course of the patient's treatment.... | Download Scientific Diagram CA15-3 tumor marker level over the course of the patient's treatment.... | Download Scientific Diagram](https://www.researchgate.net/publication/318847012/figure/fig2/AS:631650916511761@1527608722402/CA15-3-tumor-marker-level-over-the-course-of-the-patients-treatment-Solid-line-CA15-3.png)
CA15-3 tumor marker level over the course of the patient's treatment.... | Download Scientific Diagram
![PDF] Correlation between Tumour Marker CA 15-3 Level and TNM Staging in Breast Cancer. - | Semantic Scholar PDF] Correlation between Tumour Marker CA 15-3 Level and TNM Staging in Breast Cancer. - | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9bc6b05499723112efa11b692439ea1e9164a0fa/4-Table5-1.png)
PDF] Correlation between Tumour Marker CA 15-3 Level and TNM Staging in Breast Cancer. - | Semantic Scholar
![CA15-3 is a useful serum tumor marker for diagnostic integration of hybrid positron emission tomography with integrated computed tomography during follow-up of breast cancer patients | BMC Cancer | Full Text CA15-3 is a useful serum tumor marker for diagnostic integration of hybrid positron emission tomography with integrated computed tomography during follow-up of breast cancer patients | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-2407-14-356/MediaObjects/12885_2013_Article_4542_Fig1_HTML.jpg)
CA15-3 is a useful serum tumor marker for diagnostic integration of hybrid positron emission tomography with integrated computed tomography during follow-up of breast cancer patients | BMC Cancer | Full Text
![CA 15-3 is predictive of response and disease recurrence following treatment in locally advanced breast cancer | BMC Cancer | Full Text CA 15-3 is predictive of response and disease recurrence following treatment in locally advanced breast cancer | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-2407-6-220/MediaObjects/12885_2006_Article_572_Fig3_HTML.jpg)
CA 15-3 is predictive of response and disease recurrence following treatment in locally advanced breast cancer | BMC Cancer | Full Text
![Survival curves for patients with CA 15-3 >30 kU/l and no metastasis at... | Download Scientific Diagram Survival curves for patients with CA 15-3 >30 kU/l and no metastasis at... | Download Scientific Diagram](https://www.researchgate.net/publication/24213426/figure/fig1/AS:460229222637571@1486738605171/Survival-curves-for-patients-with-CA-15-3-30-kU-l-and-no-metastasis-at-diagnosis-M2-as.png)
Survival curves for patients with CA 15-3 >30 kU/l and no metastasis at... | Download Scientific Diagram
![A FRET immunosensor for sensitive detection of CA 15-3 tumor marker in human serum sample and breast cancer cells using antibody functionalized luminescent carbon-dots and AuNPs-dendrimer aptamer as donor-acceptor pair - ScienceDirect A FRET immunosensor for sensitive detection of CA 15-3 tumor marker in human serum sample and breast cancer cells using antibody functionalized luminescent carbon-dots and AuNPs-dendrimer aptamer as donor-acceptor pair - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0003269718304263-fx1.jpg)
A FRET immunosensor for sensitive detection of CA 15-3 tumor marker in human serum sample and breast cancer cells using antibody functionalized luminescent carbon-dots and AuNPs-dendrimer aptamer as donor-acceptor pair - ScienceDirect
![The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer | Breast Cancer Management The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer | Breast Cancer Management](https://www.futuremedicine.com/cms/10.2217/bmt-2020-0015/asset/images/medium/figure1.gif)
The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer | Breast Cancer Management
![Determination of the prognostic value of preoperative CA15‑3 and CEA in predicting the prognosis of young patients with breast cancer Determination of the prognostic value of preoperative CA15‑3 and CEA in predicting the prognosis of young patients with breast cancer](https://www.spandidos-publications.com/article_images/ol/16/4/ol-16-04-4679-g00.jpg)
Determination of the prognostic value of preoperative CA15‑3 and CEA in predicting the prognosis of young patients with breast cancer
![Elevation of serum CEA and CA15‑3 levels during antitumor therapy predicts poor therapeutic response in advanced breast cancer patients Elevation of serum CEA and CA15‑3 levels during antitumor therapy predicts poor therapeutic response in advanced breast cancer patients](https://www.spandidos-publications.com/article_images/ol/14/6/ol-14-06-7549-g01.jpg)
Elevation of serum CEA and CA15‑3 levels during antitumor therapy predicts poor therapeutic response in advanced breast cancer patients
![Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0960977620301120-gr2.jpg)